|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Direct costs | |||||
| Costs and expenses: | |||||
| Direct costs | |||||
| Selling, general and administrative | |||||
| Depreciation and amortization | |||||
| Transaction and integration related (Note 6) | |||||
| Transaction and integration related | |||||
| Restructuring | |||||
| Goodwill impairment | |||||
| Impairment of non-financial assets | |||||
| Total costs and expenses | |||||
| Income from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Income before income tax expense | |||||
| Income tax expense | |||||
| Income before share of losses from equity method investments | |||||
| Share of losses from equity method investments | |||||
| Net income | |||||
| Net income per ordinary share: | |||||
| Basic (USD per share) | |||||
| Diluted (USD per share) | |||||
| Weighted average number of ordinary shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...